S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
Watch for your Federal QR code (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Watch for your Federal QR code (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Watch for your Federal QR code (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
Watch for your Federal QR code (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Watch for your Federal QR code (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Watch for your Federal QR code (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
Watch for your Federal QR code (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Watch for your Federal QR code (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Watch for your Federal QR code (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
Watch for your Federal QR code (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Watch for your Federal QR code (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Watch for your Federal QR code (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers

Inhibrx (INBX) News Today

$24.97
-0.39 (-1.54%)
(As of 12/8/2023 ET)
Compare
Today's Range
$23.83
$25.57
50-Day Range
$14.50
$25.56
52-Week Range
$14.31
$30.71
Volume
348,372 shs
Average Volume
407,995 shs
Market Capitalization
$1.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$36.50
SourceHeadline
morningstar.com logoInhibrx Inc Ordinary Shares INBX
morningstar.com - December 9 at 12:42 PM
MarketBeat logoContrasting Cullinan Oncology (NASDAQ:CGEM) & Inhibrx (NASDAQ:INBX)
americanbankingnews.com - December 7 at 3:46 AM
MarketBeat logoInhibrx, Inc. (NASDAQ:INBX) Short Interest Up 5.4% in November
americanbankingnews.com - December 4 at 2:40 AM
morningstar.com logoInhibrx Inc Ordinary Shares
morningstar.com - December 2 at 12:50 PM
msn.com logoInhibrx posts Q3 results
msn.com - November 10 at 1:16 PM
finanznachrichten.de logoInhibrx, Inc.: Inhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
finanznachrichten.de - November 10 at 8:16 AM
finance.yahoo.com logoInhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
finance.yahoo.com - November 9 at 8:10 PM
msn.com logoInhibrx reports initial Phase I Ewing sarcoma trial data
msn.com - November 4 at 7:27 AM
finance.yahoo.com logoInhibrx Announces Preliminary Data from the Phase 1 Trial of INBRX-109 for the Treatment of Ewing Sarcoma
finance.yahoo.com - November 2 at 1:13 PM
finance.yahoo.com logoInhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States and Canada
finance.yahoo.com - September 19 at 6:29 PM
marketbeat.com logoCitigroup Inc. Buys 37,822 Shares of Inhibrx, Inc. (NASDAQ:INBX)
marketbeat.com - September 6 at 4:41 AM
marketwatch.com logoInhibrx Shares Rise 15% After Private Placement Financing
marketwatch.com - August 29 at 3:34 PM
finance.yahoo.com logoInhibrx Announces $200 Million Private Placement Financing
finance.yahoo.com - August 29 at 10:09 AM
markets.businessinsider.com logoJMP Securities Maintains Outperform Rating for Inhibrx: Here's What You Need To Know
markets.businessinsider.com - August 23 at 4:06 PM
nasdaq.com logoJMP Securities Maintains Inhibrx (INBX) Outperform Recommendation
nasdaq.com - August 23 at 9:45 AM
markets.businessinsider.com logoJMP Securities Reaffirms Their Buy Rating on Inhibrx (INBX)
markets.businessinsider.com - August 23 at 4:45 AM
marketbeat.com logoInhibrx, Inc. (NASDAQ:INBX) Shares Sold by Barclays PLC
marketbeat.com - August 21 at 4:35 AM
marketbeat.com logoInhibrx, Inc. (NASDAQ:INBX) Forecasted to Post Q3 2023 Earnings of ($0.96) Per Share
marketbeat.com - August 21 at 1:52 AM
msn.com logoInhibrx: INBRX-101 Developments Constructive, Market-Generated Data Not So Much
msn.com - August 17 at 9:20 PM
markets.businessinsider.com logoLifeSci Capital Sticks to Their Buy Rating for Inhibrx (INBX)
markets.businessinsider.com - August 16 at 6:37 PM
marketbeat.com logoInhibrx's (INBX) "Outperform" Rating Reaffirmed at Lifesci Capital
marketbeat.com - August 11 at 11:27 AM
marketbeat.com logoInhibrx, Inc. Expected to Post FY2023 Earnings of ($3.99) Per Share (NASDAQ:INBX)
marketbeat.com - August 11 at 10:00 AM
finance.yahoo.com logoInhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
finance.yahoo.com - August 8 at 11:11 AM
marketbeat.com logoInhibrx, Inc. (NASDAQ:INBX) Stock Position Lowered by Los Angeles Capital Management LLC
marketbeat.com - August 8 at 5:49 AM
marketbeat.com logoJump Financial LLC Decreases Holdings in Inhibrx, Inc. (NASDAQ:INBX)
marketbeat.com - August 7 at 7:34 AM
marketbeat.com logoVirtu Financial LLC Acquires Shares of 10,369 Inhibrx, Inc. (NASDAQ:INBX)
marketbeat.com - July 28 at 5:47 AM
marketwatch.com logoTheft in open court: How a fight over lifesaving drugs led to accusations of brazen industrial espionage
marketwatch.com - June 27 at 1:19 PM
marketbeat.com logoGSA Capital Partners LLP Takes Position in Inhibrx, Inc. (NASDAQ:INBX)
marketbeat.com - June 7 at 7:27 AM
marketbeat.com logoInhibrx, Inc. (NASDAQ:INBX) Shares Purchased by UBS Group AG
marketbeat.com - June 5 at 4:37 AM
finance.yahoo.com logoInhibrx Granted Fast Track Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency
finance.yahoo.com - May 30 at 1:31 PM
marketbeat.com logoInhibrx, Inc. (NASDAQ:INBX) Stake Decreased by Citigroup Inc.
marketbeat.com - May 25 at 5:35 AM
msn.com logoJMP Securities Reiterates Inhibrx (INBX) Market Outperform Recommendation
msn.com - May 11 at 9:18 PM
finanznachrichten.de logoInhibrx Inc.: Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
finanznachrichten.de - May 9 at 1:49 PM
finance.yahoo.com logoInhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
finance.yahoo.com - May 8 at 8:47 PM
finance.yahoo.com logoInhibrx, Inc. (INBX) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 8 at 8:47 PM
msn.com logoStrength Seen in Inhibrx, Inc. (INBX): Can Its 9.9% Jump Turn into More Strength?
msn.com - May 4 at 4:22 AM
marketbeat.com logoLos Angeles Capital Management LLC Sells 19,631 Shares of Inhibrx, Inc. (NASDAQ:INBX)
marketbeat.com - May 3 at 5:26 AM
nasdaq.com logoINBX Makes Bullish Cross Above Critical Moving Average
nasdaq.com - May 1 at 11:26 PM
marketbeat.com logoInhibrx, Inc. Expected to Earn FY2023 Earnings of ($3.99) Per Share (NASDAQ:INBX)
marketbeat.com - May 1 at 3:21 AM
msn.com logoInhibrx Resumes Patient Enrollment In INBRX-109 Studies In Cancer Patients
msn.com - April 26 at 8:26 PM
finance.yahoo.com logoInhibrx Initiates a Registration-Enabling Trial of INBRX-101 in AATD and Announces Lift of Partial Clinical Hold on INBRX-109 DR5 Agonist Trials
finance.yahoo.com - April 26 at 9:50 AM
seekingalpha.com logoInhibrx: Undercovered Company With Good Potential
seekingalpha.com - April 13 at 11:12 AM
finance.yahoo.com logoThe past year for Inhibrx (NASDAQ:INBX) investors has not been profitable
finance.yahoo.com - March 23 at 8:03 AM
benzinga.com logoInhibrx Stock (NASDAQ:INBX), Analyst Ratings, Price Targets, Predictions
benzinga.com - March 13 at 5:39 AM
finanznachrichten.de logoInhibrx Inc.: Inhibrx Reports Fourth Quarter and Fiscal Year 2022 Financial Results
finanznachrichten.de - March 7 at 6:21 AM
msn.com logoInhibrx GAAP EPS of -$0.95 misses by $0.16, revenue of $0.27M misses by $0.52M
msn.com - March 6 at 8:21 PM
finance.yahoo.com logoInhibrx Reports Fourth Quarter and Fiscal Year 2022 Financial Results
finance.yahoo.com - March 6 at 8:21 PM
finance.yahoo.com logoInhibrx, Inc. (INBX) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 6 at 8:21 PM
marketbeat.com logoCubist Systematic Strategies LLC Has $1.38 Million Stake in Inhibrx, Inc. (NASDAQ:INBX)
marketbeat.com - February 10 at 1:17 PM
marketbeat.com logoSG Americas Securities LLC Takes Position in Inhibrx, Inc. (NASDAQ:INBX)
marketbeat.com - February 8 at 4:13 AM
Get Inhibrx News Delivered to You Automatically

Sign up to receive the latest news and ratings for INBX and its competitors with MarketBeat's FREE daily newsletter.



INBX Media Mentions By Week

INBX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INBX
News Sentiment

0.14

0.52

Average
Medical
News Sentiment

INBX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INBX Articles
This Week

4

1

INBX Articles
Average Week

Get Inhibrx News Delivered to You Automatically

Sign up to receive the latest news and ratings for INBX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:INBX) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -